Holdings (as at 2026-08-07)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Regeneron Pharmaceuticals, Inc. 2.75%
Natera, Inc. 2.60%
Universal Health Services, Inc. (Class B) 2.55%
Boston Scientific Corporation 2.53%
Guardant Health, Inc. 2.46%
Zimmer Biomet Holdings, Inc. 2.45%
Pfizer Inc. 2.43%
Solventum Corporation 2.35%
Tenet Healthcare Corporation 2.29%
Globus Medical, Inc. (Class A) 2.28%
Centene Corporation 2.24%
The Cigna Group 2.24%
Halozyme Therapeutics, Inc. 2.15%
Corcept Therapeutics Inc. 2.08%
Encompass Health Corporation 2.02%
Medline Inc. (Class A) 1.95%
Axsome Therapeutics, Inc. 1.90%
Medtronic Plc 1.82%
DaVita Inc. 1.81%
ResMed Inc. 1.78%
QIAGEN N.V. 1.77%
Arrowhead Pharmaceuticals, Inc. 1.76%
Incyte Corporation 1.74%
Doximity, Inc. (Class A) 1.73%
Elevance Health Inc. 1.66%
Zoetis Inc. 1.65%
United Therapeutics Corporation 1.62%
Eli Lilly and Company 1.61%
Neurocrine Biosciences, Inc. 1.58%
Ascendis Pharma A/S 1.57%
Becton, Dickinson and Company 1.53%
Labcorp Holdings Inc. 1.50%
Quest Diagnostics Incorporated 1.48%
Steris Plc 1.48%
Bristol-Myers Squibb Company 1.47%
Medpace Holdings, Inc. 1.47%
GE HealthCare Technologies Inc. 1.47%
Revolution Medicines, Inc. 1.44%
Gilead Sciences, Inc. 1.38%
Viatris Inc. 1.36%
Exelixis, Inc. 1.30%
Biogen Inc. 1.26%
Veeva Systems Inc. (Class A) 1.06%
IQVIA Holdings Inc. 1.01%
Abbott Laboratories 0.97%
Thermo Fisher Scientific Inc. 0.97%
Chemed Corporation 0.97%
Ionis Pharmaceuticals, Inc. 0.94%
BridgeBio Pharma, Inc. 0.93%
Agilent Technologies, Inc. 0.90%
HCA Healthcare, Inc. 0.87%
Henry Schein, Inc. 0.86%
Align Technology, Inc. 0.84%
Vertex Pharmaceuticals Incorporated 0.82%
Organon & Co. 0.82%
AbbVie Inc. 0.80%
Madrigal Pharmaceuticals, Inc. 0.78%
Tempus AI, Inc. (Class A) 0.73%
DexCom, Inc. 0.51%
Bio-Rad Laboratories, Inc. (Class A) 0.49%
The Ensign Group, Inc. 0.47%
Amgen Inc. 0.46%
BioMarin Pharmaceutical Inc. 0.46%
IDEXX Laboratories, Inc. 0.45%
Danaher Corporation 0.44%
Stryker Corporation 0.44%
Illumina, Inc. 0.44%
Envista Holdings Corporation 0.44%
Johnson & Johnson 0.42%
The Cooper Companies, Inc. 0.42%
Revvity, Inc. 0.42%
Merck & Co., Inc. 0.41%
West Pharmaceutical Services, Inc. 0.40%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.